IPMP website addresses are provided for general information, enrollment, requests for information or data, uploading data, and statistics. Contact information is provided for the IPMP Executive Officer and Associate Director. Data for 2017 cover the state population (3,150,553), DEA registered prescribers (16,124), and DEA registered dispensers (731). IPMP available reports are listed. IPMP funding sources reported for 2018 were controlled substance registration fees, a Harold Rogers grant, and a SAMHSA grant. For 2018, IPMP employment numbers are reported for the following job categories: operational (1.5), technical (0), analytical (0.25), and "other" (0). Significant IPMP dates are for enabling legislation (May 2006), becoming operational (January 2009), initial user access (February 2009), on-line access (March 2009), and electronic reporting (January 2009). Access information is provided for statutes and rules relevant to the IPMP operation. IPMP monitors data on the prescription and dispensing of controlled substances on schedules II, III, IV, and V, and it can remove drugs from monitoring, Information is also collected on the administering and dispensing of naloxone. Miscellaneous capabilities and policies are listed. Prescribers are required to enroll with and use IPMP. This is not required of dispensers of prescription drugs. Law enforcement access to IPMP data requires a subpoena and court order, which must be submitted on-line. IPMP has a data retention policy, and all information can be purged. Training on IPMP use is available for prescribers, dispensers, law enforcement personnel, and regulatory board members. A review of technological capabilities addresses ASAP versions accepted; data transmission methods allowed; required data transmitters; data collection, storage, generation, and access; interstate data sharing; and patient matching. Reports authorized and produced by data requestors are listed.